Page last updated: 2024-10-22

amitriptyline and Nocturnal Wandering

amitriptyline has been researched along with Nocturnal Wandering in 3 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bahro, M1
Katzmann, KJ1
Gückel, F1
Sungurtekin, I1
Riemann, D1
Ferrándiz-Santos, JA1
Mataix-Sanjuan, AL1
Huapaya, LV1

Other Studies

3 other studies available for amitriptyline and Nocturnal Wandering

ArticleYear
[REM sleep parasomnia].
    Der Nervenarzt, 1994, Volume: 65, Issue:8

    Topics: Amitriptyline; Brain Stem; Carbamazepine; Cerebral Infarction; Dreams; Drug Therapy, Combination; Hu

1994
Amitriptyline and somnambulism.
    The Annals of pharmacotherapy, 2000, Volume: 34, Issue:10

    Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Female; Humans; Middle Aged; Somnambulism

2000
Seven cases of somnambulism induced by drugs.
    The American journal of psychiatry, 1979, Volume: 136, Issue:7

    Topics: Adult; Alcoholism; Amitriptyline; Chlorprothixene; Depression; Drug Therapy, Combination; Ethchlorvy

1979